Congressional Medicaid advisers said Thursday (March 4) that next month they will vote on a recommendation to hike Medicaid rebates on drugs that receive accelerated FDA approvals. However, members of the Medicaid and CHIP Payment and Access Commission did not discuss at their March 4 meeting a separate policy to cover expensive cell and gene therapies outside of the Medicaid Drug Rebate Program, even though last month MACPAC commissioners talked about pursuing both policies . The higher rebates that MACPAC...